The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Normal Saline for Parenteral Use Market Research Report 2024
Synopsis
Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.
This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection
The global Normal Saline for Parenteral Use market was valued at US$ 3135.1 million in 2023 and is anticipated to reach US$ 3918.8 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
At present, Baxter, Kelun Group, B. Braun, Fresenius Kabi and SSY Group are the top five manufacturers of gastrointestinal saline in the world, with a total market share of more than 45%.They are also the world's largest companies by sales.
This report aims to provide a comprehensive presentation of the global market for Normal Saline for Parenteral Use, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Normal Saline for Parenteral Use.
Report Scope
The Normal Saline for Parenteral Use market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Normal Saline for Parenteral Use market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Normal Saline for Parenteral Use manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Pfizer
B. Braun
ICU Medical
Fresenius Kabi
Otsuka
Kelun Group
CR Double-Cran
SSY Group
Cisen Pharmaceutical
Denis Chem Lab Limited
Shree Krishnakeshav Laboratories
Pharmally International
Segment by Type
Flexible Bag
Plastic Bottles
Glass Bottles
Segment by Application
Intramuscular Injection
Intravenous Injection
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Normal Saline for Parenteral Use manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Normal Saline for Parenteral Use in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.
This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection
The global Normal Saline for Parenteral Use market was valued at US$ 3135.1 million in 2023 and is anticipated to reach US$ 3918.8 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
At present, Baxter, Kelun Group, B. Braun, Fresenius Kabi and SSY Group are the top five manufacturers of gastrointestinal saline in the world, with a total market share of more than 45%.They are also the world's largest companies by sales.
This report aims to provide a comprehensive presentation of the global market for Normal Saline for Parenteral Use, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Normal Saline for Parenteral Use.
Report Scope
The Normal Saline for Parenteral Use market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Normal Saline for Parenteral Use market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Normal Saline for Parenteral Use manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Pfizer
B. Braun
ICU Medical
Fresenius Kabi
Otsuka
Kelun Group
CR Double-Cran
SSY Group
Cisen Pharmaceutical
Denis Chem Lab Limited
Shree Krishnakeshav Laboratories
Pharmally International
Segment by Type
Flexible Bag
Plastic Bottles
Glass Bottles
Segment by Application
Intramuscular Injection
Intravenous Injection
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Normal Saline for Parenteral Use manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Normal Saline for Parenteral Use in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Normal Saline for Parenteral Use Market Overview
1.1 Product Overview and Scope of Normal Saline for Parenteral Use
1.2 Normal Saline for Parenteral Use Segment by Type
1.2.1 Global Normal Saline for Parenteral Use Market Value Comparison by Type (2024-2030)
1.2.2 Flexible Bag
1.2.3 Plastic Bottles
1.2.4 Glass Bottles
1.3 Normal Saline for Parenteral Use Segment by Application
1.3.1 Global Normal Saline for Parenteral Use Market Value by Application: (2024-2030)
1.3.2 Intramuscular Injection
1.3.3 Intravenous Injection
1.3.4 Others
1.4 Global Normal Saline for Parenteral Use Market Size Estimates and Forecasts
1.4.1 Global Normal Saline for Parenteral Use Revenue 2019-2030
1.4.2 Global Normal Saline for Parenteral Use Sales 2019-2030
1.4.3 Global Normal Saline for Parenteral Use Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Normal Saline for Parenteral Use Market Competition by Manufacturers
2.1 Global Normal Saline for Parenteral Use Sales Market Share by Manufacturers (2019-2024)
2.2 Global Normal Saline for Parenteral Use Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Normal Saline for Parenteral Use Average Price by Manufacturers (2019-2024)
2.4 Global Normal Saline for Parenteral Use Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Normal Saline for Parenteral Use, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Normal Saline for Parenteral Use, Product Type & Application
2.7 Normal Saline for Parenteral Use Market Competitive Situation and Trends
2.7.1 Normal Saline for Parenteral Use Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Normal Saline for Parenteral Use Players Market Share by Revenue
2.7.3 Global Normal Saline for Parenteral Use Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Normal Saline for Parenteral Use Retrospective Market Scenario by Region
3.1 Global Normal Saline for Parenteral Use Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Normal Saline for Parenteral Use Global Normal Saline for Parenteral Use Sales by Region: 2019-2030
3.2.1 Global Normal Saline for Parenteral Use Sales by Region: 2019-2024
3.2.2 Global Normal Saline for Parenteral Use Sales by Region: 2025-2030
3.3 Global Normal Saline for Parenteral Use Global Normal Saline for Parenteral Use Revenue by Region: 2019-2030
3.3.1 Global Normal Saline for Parenteral Use Revenue by Region: 2019-2024
3.3.2 Global Normal Saline for Parenteral Use Revenue by Region: 2025-2030
3.4 North America Normal Saline for Parenteral Use Market Facts & Figures by Country
3.4.1 North America Normal Saline for Parenteral Use Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Normal Saline for Parenteral Use Sales by Country (2019-2030)
3.4.3 North America Normal Saline for Parenteral Use Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Normal Saline for Parenteral Use Market Facts & Figures by Country
3.5.1 Europe Normal Saline for Parenteral Use Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Normal Saline for Parenteral Use Sales by Country (2019-2030)
3.5.3 Europe Normal Saline for Parenteral Use Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Normal Saline for Parenteral Use Market Facts & Figures by Country
3.6.1 Asia Pacific Normal Saline for Parenteral Use Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Normal Saline for Parenteral Use Sales by Country (2019-2030)
3.6.3 Asia Pacific Normal Saline for Parenteral Use Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Normal Saline for Parenteral Use Market Facts & Figures by Country
3.7.1 Latin America Normal Saline for Parenteral Use Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Normal Saline for Parenteral Use Sales by Country (2019-2030)
3.7.3 Latin America Normal Saline for Parenteral Use Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Normal Saline for Parenteral Use Market Facts & Figures by Country
3.8.1 Middle East and Africa Normal Saline for Parenteral Use Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Normal Saline for Parenteral Use Sales by Country (2019-2030)
3.8.3 Middle East and Africa Normal Saline for Parenteral Use Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Normal Saline for Parenteral Use Sales by Type (2019-2030)
4.1.1 Global Normal Saline for Parenteral Use Sales by Type (2019-2024)
4.1.2 Global Normal Saline for Parenteral Use Sales by Type (2025-2030)
4.1.3 Global Normal Saline for Parenteral Use Sales Market Share by Type (2019-2030)
4.2 Global Normal Saline for Parenteral Use Revenue by Type (2019-2030)
4.2.1 Global Normal Saline for Parenteral Use Revenue by Type (2019-2024)
4.2.2 Global Normal Saline for Parenteral Use Revenue by Type (2025-2030)
4.2.3 Global Normal Saline for Parenteral Use Revenue Market Share by Type (2019-2030)
4.3 Global Normal Saline for Parenteral Use Price by Type (2019-2030)
5 Segment by Application
5.1 Global Normal Saline for Parenteral Use Sales by Application (2019-2030)
5.1.1 Global Normal Saline for Parenteral Use Sales by Application (2019-2024)
5.1.2 Global Normal Saline for Parenteral Use Sales by Application (2025-2030)
5.1.3 Global Normal Saline for Parenteral Use Sales Market Share by Application (2019-2030)
5.2 Global Normal Saline for Parenteral Use Revenue by Application (2019-2030)
5.2.1 Global Normal Saline for Parenteral Use Revenue by Application (2019-2024)
5.2.2 Global Normal Saline for Parenteral Use Revenue by Application (2025-2030)
5.2.3 Global Normal Saline for Parenteral Use Revenue Market Share by Application (2019-2030)
5.3 Global Normal Saline for Parenteral Use Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Normal Saline for Parenteral Use Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Normal Saline for Parenteral Use Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.3.4 B. Braun Normal Saline for Parenteral Use Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 ICU Medical
6.4.1 ICU Medical Corporation Information
6.4.2 ICU Medical Description and Business Overview
6.4.3 ICU Medical Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ICU Medical Normal Saline for Parenteral Use Product Portfolio
6.4.5 ICU Medical Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Corporation Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fresenius Kabi Normal Saline for Parenteral Use Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Otsuka Normal Saline for Parenteral Use Product Portfolio
6.6.5 Otsuka Recent Developments/Updates
6.7 Kelun Group
6.6.1 Kelun Group Corporation Information
6.6.2 Kelun Group Description and Business Overview
6.6.3 Kelun Group Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kelun Group Normal Saline for Parenteral Use Product Portfolio
6.7.5 Kelun Group Recent Developments/Updates
6.8 CR Double-Cran
6.8.1 CR Double-Cran Corporation Information
6.8.2 CR Double-Cran Description and Business Overview
6.8.3 CR Double-Cran Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CR Double-Cran Normal Saline for Parenteral Use Product Portfolio
6.8.5 CR Double-Cran Recent Developments/Updates
6.9 SSY Group
6.9.1 SSY Group Corporation Information
6.9.2 SSY Group Description and Business Overview
6.9.3 SSY Group Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SSY Group Normal Saline for Parenteral Use Product Portfolio
6.9.5 SSY Group Recent Developments/Updates
6.10 Cisen Pharmaceutical
6.10.1 Cisen Pharmaceutical Corporation Information
6.10.2 Cisen Pharmaceutical Description and Business Overview
6.10.3 Cisen Pharmaceutical Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cisen Pharmaceutical Normal Saline for Parenteral Use Product Portfolio
6.10.5 Cisen Pharmaceutical Recent Developments/Updates
6.11 Denis Chem Lab Limited
6.11.1 Denis Chem Lab Limited Corporation Information
6.11.2 Denis Chem Lab Limited Normal Saline for Parenteral Use Description and Business Overview
6.11.3 Denis Chem Lab Limited Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Denis Chem Lab Limited Normal Saline for Parenteral Use Product Portfolio
6.11.5 Denis Chem Lab Limited Recent Developments/Updates
6.12 Shree Krishnakeshav Laboratories
6.12.1 Shree Krishnakeshav Laboratories Corporation Information
6.12.2 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Description and Business Overview
6.12.3 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Product Portfolio
6.12.5 Shree Krishnakeshav Laboratories Recent Developments/Updates
6.13 Pharmally International
6.13.1 Pharmally International Corporation Information
6.13.2 Pharmally International Normal Saline for Parenteral Use Description and Business Overview
6.13.3 Pharmally International Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Pharmally International Normal Saline for Parenteral Use Product Portfolio
6.13.5 Pharmally International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Normal Saline for Parenteral Use Industry Chain Analysis
7.2 Normal Saline for Parenteral Use Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Normal Saline for Parenteral Use Production Mode & Process
7.4 Normal Saline for Parenteral Use Sales and Marketing
7.4.1 Normal Saline for Parenteral Use Sales Channels
7.4.2 Normal Saline for Parenteral Use Distributors
7.5 Normal Saline for Parenteral Use Customers
8 Normal Saline for Parenteral Use Market Dynamics
8.1 Normal Saline for Parenteral Use Industry Trends
8.2 Normal Saline for Parenteral Use Market Drivers
8.3 Normal Saline for Parenteral Use Market Challenges
8.4 Normal Saline for Parenteral Use Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
